This move is archived. Current quotes and coverage live on the stock page.
Get AVCR alerts:
Avricore Health Inc. shares surged by 7.69% in the last trading session, reflecting growing investor confidence.
In a notable turn of events, Avricore Health Inc. (AVCR.V) saw its stock price rise significantly, closing at CA$0.07. This 7.69% increase signals a positive shift in market sentiment towards the company, especially as it continues to expand its innovative HealthTab™ platform in the UK.
Advertisement
Avricore Health Inc
AVCR.V
AVCR.V
Avricore Health Inc
WealthAwesomeMarket cap
$6.95M
52W high
$0.10
52W low
$0.04
1W change
+27.27%
Beta
0.32
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on AVCR's historical volatility
30-Day Vol
145.8%
Annualized
90-Day Vol
121.1%
Annualized
Trend (90d)
+31.1%
Annualized drift
90d Mean
C$0.08
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | C$0.07 | C$0.04 – C$0.12 |
| 60 trading days | C$0.08 | C$0.04 – C$0.15 |
| 90 trading days | C$0.08 | C$0.03 – C$0.19 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
Advertisement
Investor takeaway: Keep an eye on Avricore's ongoing expansion efforts and financial health, as these factors could impact future stock performance.
Stock Price Increases by 7.69%
Avricore Health Inc.'s stock closed at CA$0.07, reflecting a significant rise that may be attributed to strategic financing and expansion plans.
Bull case
The recent financing of CA$1.254 million puts Avricore Health in a strong position to speed up its UK expansion. This could boost revenue and help the company gain a larger share of the healthcare technology market.
Bear case
Despite the positive movement, Avricore's current market cap of CA$8.8 million and its lack of profitability raise concerns about its long-term sustainability and ability to compete effectively.
Recent Performance Highlights
Advertisement
Avricore Health Inc. has seen a notable increase in its stock price, closing at CA$0.07 after a 7.69% rise in the last trading session. This boost may reflect investor optimism surrounding the company's strategic initiatives and expansion plans.
Strategic Financing and Growth Plans
The completion of a CA$1.254 million financing round shows Avricore's commitment to funding its expansion of the HealthTab™ platform in the UK. This move is crucial as the company aims to strengthen its presence in the healthcare technology sector, which could lead to increased revenue potential.
Market Outlook
While the recent surge in stock price is promising, investors should remain cautious. Avricore's market cap of CA$8.8 million and its current lack of profitability are factors that could impact long-term performance. Keeping track of the company's progress and financial health will be essential for potential investors.
Best next step
Keep exploring this topic
If you want to go deeper, these are the most useful follow-up pages and tools for this topic.
Broker comparison
Best trading platforms in Canada
Compare $0-commission brokers before you act on a ticker story.
Safe cash
Best GIC rates in Canada
If the story makes you want to de-risk, compare guaranteed rates next.
HISA roundup
Best high-interest savings accounts
Keep dry powder in a no-fee savings account instead of chequing.
TFSA room
Check TFSA contribution room
Shelter the next contribution before you buy.
Advertisement
Wealth Awesome
Timely coverage of Canadian stocks, earnings, dividends, and market movers for DIY investors. Stories are checked against exchange data and public filings.
View Full Profile →✅ Reviewed by Certified Financial Professionals
This content has been reviewed by CFA® charterholders and Certified Financial Planners (CFP®) with over a decade of experience in Canadian financial markets. All information is fact-checked against official Canadian sources and regulations.
Why these credentials matter: CFA® charterholders complete 900+ hours of rigorous study in investment analysis and ethics. CFP® professionals are held to the highest standards of financial planning competency and fiduciary duty in Canada.
⚠️ Professional Disclaimer
This content is for educational purposes only and should not be considered personalized financial advice. While our team brings professional expertise, individual circumstances vary. For personalized guidance, consult with a qualified financial advisor, tax professional, or mortgage specialist.
